Patricia Carr sold $456k of JAZZ
SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc. 2,370 shares at an average of $192.60, traded Feb 26, 2026, filed Mar 2, 2026.
Score components
- +15RoleOfficer
- +17Trade size$456k at market
- +5Share of holdings soldSold 20% of holdings
- +15Cluster5 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001784606-26-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | AGrant or award Ordinary Shares | +2,223 | $0.00 | $0 | 11,605 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -1,253 | $194.11 | $243k | 10,352 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Ordinary Shares | -1,117 | $190.91 | $213k | 9,235 | Mar 2, 2026 |
Related signals
Other insiders at Jazz Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Jazz Pharmaceuticals plc | Renee D Gala President & CEO | $473k 2,000 shares | -1% | |
| 28Weak | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.4M 6,000 shares | -2% | |
| 24Weak | Jazz Pharmaceuticals plc | Neena M Patil EVP & Chief Legal Officer | $289k 1,200 shares | -2% | |
| 38Weak | Jazz Pharmaceuticals plc | Renee D Gala President & CEO | $486k 2,000 shares | -1% | |
| 45Moderate | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.5M 6,000 shares | -2% | |
| 48Moderate | Jazz Pharmaceuticals plc | Patricia Carr SVP, Chief Accounting Officer | $235k 1,287 shares | -17% | |
| 35Weak | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.1M 6,000 shares | -1% | |
| 60Notable | Jazz Pharmaceuticals plc | Mary Elizabeth Henderson SVP, Technical Operations | $1.0M 5,343 shares | -16% | |
| 45Moderate | Jazz Pharmaceuticals plc | Norbert G Riedel director | $656k 3,415 shares | -33% | |
| 60Notable | Jazz Pharmaceuticals plc | Neena M Patil EVP & Chief Legal Officer | $11M 55,600 shares | -76% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.